The TNF Receptor Superfamily-NF-κB Axis Is Critical to Maintain Effector Regulatory T Cells in Lymphoid and Non-lymphoid Tissues

Cell Reports

Volumn 20, Issue 12, 2017, Pages 2906-2920

  Vasanthakumar, Ajithkumar ^a,b   Liao, Yang ^a,b   Teh, Peggy ^a,b,c   Pascutti, Maria F ^d   Oja, Anna E ^d   Garnham, Alexandra L ^a,b   Gloury, Renee ^a,b   Tempany, Jessica C ^a,b   Sidwell, Tom ^a,b   Cuadrado, Eloy ^d   Tuijnenburg, Paul ^d   Kuijpers, Taco W ^d   Lalaoui, Najoua ^a,b   Mielke, Lisa A ^a,b   Bryant, Vanessa L ^a,b   Hodgkin, Philip D ^a,b   Silke, John ^a,b   Smyth, Gordon K ^a,b   Nolte, Martijn A ^d   Shi, Wei ^a,b   Kallies, Axel ^a,b   more..

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c WESTERN HEALTH   (Australia)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

effector Treg cells; IRF4; NF B RelA; ROR t+ Treg cells; TCR; tissue Treg cells; TNFRSF signaling

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SMALL INTESTINE; ANIMAL; CYTOLOGY; HOMEOSTASIS; INTESTINE; METABOLISM;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; HOMEOSTASIS; HUMANS; INTERFERON REGULATORY FACTORS; INTESTINES; LYMPHOID TISSUE; MICE; NF-KAPPA B; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTOR RELA;

EID: 85029572464     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2017.08.068     Document Type: Article

References (59)

1. Algül, H., Treiber, M., Lesina, M., Nakhai, H., Saur, D., Geisler, F., Pfeifer, A., Paxian, S., Schmid, R.M., Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis. J. Clin. Invest. 117 (2007), 1490–1501.
2. Arpaia, N., Green, J.A., Moltedo, B., Arvey, A., Hemmers, S., Yuan, S., Treuting, P.M., Rudensky, A.Y., A distinct function of regulatory T cells in tissue protection. Cell 162 (2015), 1078–1089.
3. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S., Baltimore, D., Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376 (1995), 167–170.
4. Boddicker, R.L., Kip, N.S., Xing, X., Zeng, Y., Yang, Z.Z., Lee, J.H., Almada, L.L., Elsawa, S.F., Knudson, R.A., Law, M.E., et al. The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma. Blood 125 (2015), 3118–3127.
5. Burzyn, D., Benoist, C., Mathis, D., Regulatory T cells in nonlymphoid tissues. Nat. Immunol. 14 (2013), 1007–1013.
6. Burzyn, D., Kuswanto, W., Kolodin, D., Shadrach, J.L., Cerletti, M., Jang, Y., Sefik, E., Tan, T.G., Wagers, A.J., Benoist, C., Mathis, D., A special population of regulatory T cells potentiates muscle repair. Cell 155 (2013), 1282–1295.
7. Chang, J.H., Xiao, Y., Hu, H., Jin, J., Yu, J., Zhou, X., Wu, X., Johnson, H.M., Akira, S., Pasparakis, M., et al. Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells. Nat. Immunol. 13 (2012), 481–490.
8. Chen, W., Jin, W., Hardegen, N., Lei, K.J., Li, L., Marinos, N., McGrady, G., Wahl, S.M., Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003), 1875–1886.
9. Chen, X., Bäumel, M., Männel, D.N., Howard, O.M.Z., Oppenheim, J.J., Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J. Immunol. 179 (2007), 154–161.
10. Chen, X., Subleski, J.J., Hamano, R., Howard, O.M., Wiltrout, R.H., Oppenheim, J.J., Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood. Eur. J. Immunol. 40 (2010), 1099–1106.
11. Chinen, T., Kannan, A.K., Levine, A.G., Fan, X., Klein, U., Zheng, Y., Gasteiger, G., Feng, Y., Fontenot, J.D., Rudensky, A.Y., An essential role for the IL-2 receptor in Treg cell function. Nat. Immunol. 17 (2016), 1322–1333.
12. Chopra, M., Riedel, S.S., Biehl, M., Krieger, S., von Krosigk, V., Bäuerlein, C.A., Brede, C., Jordan Garrote, A.L., Kraus, S., Schäfer, V., et al. Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis. Carcinogenesis 34 (2013), 1296–1303.
13. Ciofani, M., Madar, A., Galan, C., Sellars, M., Mace, K., Pauli, F., Agarwal, A., Huang, W., Parkhurst, C.N., Muratet, M., et al. A validated regulatory network for Th17 cell specification. Cell 151 (2012), 289–303.
14. Cretney, E., Xin, A., Shi, W., Minnich, M., Masson, F., Miasari, M., Belz, G.T., Smyth, G.K., Busslinger, M., Nutt, S.L., Kallies, A., The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 12 (2011), 304–311.
15. Cretney, E., Kallies, A., Nutt, S.L., Differentiation and function of Foxp3(+) effector regulatory T cells. Trends Immunol. 34 (2013), 74–80.
16. Esparza, E.M., Arch, R.H., Glucocorticoid-induced TNF receptor, a costimulatory receptor on naive and activated T cells, uses TNF receptor-associated factor 2 in a novel fashion as an inhibitor of NF-kappa B activation. J. Immunol. 174 (2005), 7875–7882.
17. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A.B., Benoist, C., Shoelson, S., Mathis, D., Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15 (2009), 930–939.
18. Fliegauf, M., Bryant, V.L., Frede, N., Slade, C., Woon, S.T., Lehnert, K., Winzer, S., Bulashevska, A., Scerri, T., Leung, E., et al. Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency. Am. J. Hum. Genet. 97 (2015), 389–403.
19. Frederiksen, A.L., Larsen, M.J., Brusgaard, K., Novack, D.V., Knudsen, P.J., Schroder, H.D., Qiu, W., Eckhardt, C., McAlister, W.H., Kassem, M., et al. Neonatal high bone mass with first mutation of the NF-kappaB complex: heterozygous de novo missense (p.Asp512Ser) RELA (Rela/p65). J. Bone Min. Res. 31 (2016), 163–172.
20. Gratz, I.K., Campbell, D.J., Organ-specific and memory treg cells: specificity, development, function, and maintenance. Front. Immunol., 5, 2014, 333.
21. Grigoriadis, G., Vasanthakumar, A., Banerjee, A., Grumont, R., Overall, S., Gleeson, P., Shannon, F., Gerondakis, S., c-Rel controls multiple discrete steps in the thymic development of Foxp3+ CD4 regulatory T cells. PLoS One, 6, 2011, e26851.
22. Griseri, T., Asquith, M., Thompson, C., Powrie, F., OX40 is required for regulatory T cell-mediated control of colitis. J. Exp. Med. 207 (2010), 699–709.
23. Grumont, R.J., Gerondakis, S., Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J. Exp. Med. 191 (2000), 1281–1292.
24. Josefowicz, S.Z., Lu, L.F., Rudensky, A.Y., Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30 (2012), 531–564.
25. Kallies, A., Hasbold, J., Tarlinton, D.M., Dietrich, W., Corcoran, L.M., Hodgkin, P.D., Nutt, S.L., Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J. Exp. Med. 200 (2004), 967–977.
26. Karin, M., How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18 (1999), 6867–6874.
27. Kaustio, M., Haapaniemi, E., Göös, H., Hautala, T., Park, G., Syrjänen, J., Einarsdottir, E., Sahu, B., Kilpinen, S., Rounioja, S., et al. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes. J. Allergy Clin. Immunol., 2017, 10.1016/j.jaci.2016.10.054 Published online Jan 21, 2017.
28. Koch, M.A., Tucker-Heard, G., Perdue, N.R., Killebrew, J.R., Urdahl, K.B., Campbell, D.J., The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10 (2009), 595–602.
29. Kolodin, D., van Panhuys, N., Li, C., Magnuson, A.M., Cipolletta, D., Miller, C.M., Wagers, A., Germain, R.N., Benoist, C., Mathis, D., Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice. Cell Metab. 21 (2015), 543–557.
30. Köntgen, F., Grumont, R.J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D., Gerondakis, S., Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9 (1995), 1965–1977.
31. Kwon, H., Thierry-Mieg, D., Thierry-Mieg, J., Kim, H.P., Oh, J., Tunyaplin, C., Carotta, S., Donovan, C.E., Goldman, M.L., Tailor, P., et al. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 31 (2009), 941–952.
32. Lalaoui, N., Lindqvist, L.M., Sandow, J.J., Ekert, P.G., The molecular relationships between apoptosis, autophagy and necroptosis. Semin. Cell Dev. Biol. 39 (2015), 63–69.
33. Levine, A.G., Arvey, A., Jin, W., Rudensky, A.Y., Continuous requirement for the TCR in regulatory T cell function. Nat. Immunol. 15 (2014), 1070–1078.
34. Li, P., Spolski, R., Liao, W., Wang, L., Murphy, T.L., Murphy, K.M., Leonard, W.J., BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 490 (2012), 543–546.
35. Liao, G., Nayak, S., Regueiro, J.R., Berger, S.B., Detre, C., Romero, X., de Waal Malefyt, R., Chatila, T.A., Herzog, R.W., Terhorst, C., GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells. Int. Immunol. 22 (2010), 259–270.
36. Linterman, M.A., Pierson, W., Lee, S.K., Kallies, A., Kawamoto, S., Rayner, T.F., Srivastava, M., Divekar, D.P., Beaton, L., Hogan, J.J., et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat. Med. 17 (2011), 975–982.
37. Mahmud, S.A., Manlove, L.S., Schmitz, H.M., Xing, Y., Wang, Y., Owen, D.L., Schenkel, J.M., Boomer, J.S., Green, J.M., Yagita, H., et al. Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells. Nat. Immunol. 15 (2014), 473–481.
38. Man, K., Miasari, M., Shi, W., Xin, A., Henstridge, D.C., Preston, S., Pellegrini, M., Belz, G.T., Smyth, G.K., Febbraio, M.A., et al. The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat. Immunol. 14 (2013), 1155–1165.
39. Matsuzawa, Y., Oshima, S., Takahara, M., Maeyashiki, C., Nemoto, Y., Kobayashi, M., Nibe, Y., Nozaki, K., Nagaishi, T., Okamoto, R., et al. TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy. Autophagy 11 (2015), 1052–1062.
40. Messina, N., Fulford, T., O'Reilly, L., Loh, W.X., Motyer, J.M., Ellis, D., McLean, C., Naeem, H., Lin, A., Gugasyan, R., et al. The NF-κB transcription factor RelA is required for the tolerogenic function of Foxp3(+) regulatory T cells. J. Autoimmun. 70 (2016), 52–62.
41. Mittrücker, H.W., Matsuyama, T., Grossman, A., Kündig, T.M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P.S., Mak, T.W., Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275 (1997), 540–543.
42. Naudé, P.J., den Boer, J.A., Luiten, P.G., Eisel, U.L., Tumor necrosis factor receptor cross-talk. FEBS J. 278 (2011), 888–898.
43. Ohnmacht, C., Park, J.H., Cording, S., Wing, J.B., Atarashi, K., Obata, Y., Gaboriau-Routhiau, V., Marques, R., Dulauroy, S., Fedoseeva, M., et al. MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells. Science 349 (2015), 989–993.
44. Pierson, W., Cauwe, B., Policheni, A., Schlenner, S.M., Franckaert, D., Berges, J., Humblet-Baron, S., Schönefeldt, S., Herold, M.J., Hildeman, D., et al. Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3⁺ regulatory T cells. Nat. Immunol. 14 (2013), 959–965.
45. Rauert, H., Wicovsky, A., Müller, N., Siegmund, D., Spindler, V., Waschke, J., Kneitz, C., Wajant, H., Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2). J. Biol. Chem. 285 (2010), 7394–7404.
46. Rickert, R.C., Jellusova, J., Miletic, A.V., Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol. Rev. 244 (2011), 115–133.
47. Ruan, Q., Kameswaran, V., Tone, Y., Li, L., Liou, H.C., Greene, M.I., Tone, M., Chen, Y.H., Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity 31 (2009), 932–940.
48. Ruan, Q., Kameswaran, V., Zhang, Y., Zheng, S., Sun, J., Wang, J., DeVirgiliis, J., Liou, H.C., Beg, A.A., Chen, Y.H., The Th17 immune response is controlled by the Rel-RORγ-RORγ T transcriptional axis. J. Exp. Med. 208 (2011), 2321–2333.
49. Saito, M., Gao, J., Basso, K., Kitagawa, Y., Smith, P.M., Bhagat, G., Pernis, A., Pasqualucci, L., Dalla-Favera, R., A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 12 (2007), 280–292.
50. Samstein, R.M., Arvey, A., Josefowicz, S.Z., Peng, X., Reynolds, A., Sandstrom, R., Neph, S., Sabo, P., Kim, J.M., Liao, W., et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151 (2012), 153–166.
51. Schiering, C., Krausgruber, T., Chomka, A., Fröhlich, A., Adelmann, K., Wohlfert, E.A., Pott, J., Griseri, T., Bollrath, J., Hegazy, A.N., et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513 (2014), 564–568.
52. Sefik, E., Geva-Zatorsky, N., Oh, S., Konnikova, L., Zemmour, D., McGuire, A.M., Burzyn, D., Ortiz-Lopez, A., Lobera, M., Yang, J., et al. MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells. Science 349 (2015), 993–997.
53. Smigiel, K.S., Richards, E., Srivastava, S., Thomas, K.R., Dudda, J.C., Klonowski, K.D., Campbell, D.J., CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. J. Exp. Med. 211 (2014), 121–136.
54. Teh, P.P., Vasanthakumar, A., Kallies, A., Development and function of effector regulatory T cells. Prog. Mol. Biol. Transl. Sci. 136 (2015), 155–174.
55. Vahl, J.C., Drees, C., Heger, K., Heink, S., Fischer, J.C., Nedjic, J., Ohkura, N., Morikawa, H., Poeck, H., Schallenberg, S., et al. Continuous T cell receptor signals maintain a functional regulatory T cell pool. Immunity 41 (2014), 722–736.
56. van Olffen, R.W., Koning, N., van Gisbergen, K.P.J.M., Wensveen, F.M., Hoek, R.M., Boon, L., Hamann, J., van Lier, R.A.W., Nolte, M.A., GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo. J. Immunol. 182 (2009), 7490–7500.
57. Vasanthakumar, A., Moro, K., Xin, A., Liao, Y., Gloury, R., Kawamoto, S., Fagarasan, S., Mielke, L.A., Afshar-Sterle, S., Masters, S.L., et al. Erratum: the transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol., 16, 2015, 544.
58. Zheng, L., Fisher, G., Miller, R.E., Peschon, J., Lynch, D.H., Lenardo, M.J., Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377 (1995), 348–351.
59. Zheng, Y., Chaudhry, A., Kas, A., deRoos, P., Kim, J.M., Chu, T.T., Corcoran, L., Treuting, P., Klein, U., Rudensky, A.Y., Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458 (2009), 351–356.